Related Experiment Video
Updated: Jun 13, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Transforming growth factor-beta regulator SnoN modulates mammary gland branching morphogenesis, postlactational
Nadine S Jahchan1, Young-Hyun You, William J Muller
1Department of Molecular and Cell Biology, University of California, Berkeley, California 94720, USA.
Abstract:
SnoN is an important negative regulator of transforming growth factor-beta (TGF-beta) signaling that was originally identified as a transforming oncogene in chicken embryonic fibroblasts. Both pro-oncogenic and antioncogenic activities of SnoN have been reported, but its function in normal epithelial cells has not been defined. In the mouse mammary gland, SnoN is expressed at relatively low levels, but it is transiently upregulated at late gestation before being downregulated during lactation and early involution. To assess the effects of elevated levels of SnoN, we generated transgenic mice expressing a SnoN fragment under the control of the mouse mammary tumor virus promoter. In this model system, SnoN elevation increased side-branching and lobular-alveolar proliferation in virgin glands, while accelerating involution in postlactation glands. Increased proliferation stimulated by SnoN was insufficient to induce mammary tumorigenesis. In contrast, elevated levels of SnoN cooperated with polyoma middle T antigen to accelerate the formation of aggressive multifocal adenocarcinomas and to increase the formation of pulmonary metastases. Our studies define functions of SnoN in mammary epithelial cell proliferation and involution, and provide the first in vivo evidence of a pro-oncogenic role for SnoN in mammalian tumorigenesis.
Insights
SnoN, a transforming growth factor-beta (TGF-beta) regulator, promotes mammary epithelial cell proliferation and accelerates involution. Elevated SnoN cooperates with oncogenes to drive aggressive mammary tumors and metastasis in mice.
Area of Science:
- Molecular Biology
- Cancer Research
- Developmental Biology
Background:
- SnoN is a key negative regulator of TGF-beta signaling.
- Its role in normal mammalian epithelial cells, particularly in mammary development, remains undefined.
- Previous studies reported both pro-oncogenic and anti-oncogenic activities of SnoN.
Purpose of the Study:
- To investigate the function of SnoN in normal mouse mammary gland epithelial cells.
- To determine the effects of elevated SnoN levels on mammary gland development and tumorigenesis.
- To provide in vivo evidence for SnoN's role in mammalian cancer progression.
Main Methods:
- Generated transgenic mice expressing a SnoN fragment under the MMTV promoter.
- Analyzed mammary gland morphology, proliferation, and involution dynamics.
- Assessed cooperation between elevated SnoN and polyoma middle T antigen in tumorigenesis.
Main Results:
- SnoN elevation increased mammary side-branching and lobular-alveolar proliferation in virgin mice.
- Elevated SnoN accelerated involution in postlactation mammary glands.
- SnoN alone did not induce mammary tumors, but cooperated with polyoma middle T antigen to accelerate aggressive adenocarcinoma formation and pulmonary metastasis.
Conclusions:
- SnoN plays critical roles in regulating mammary epithelial cell proliferation and gland involution.
- This study provides the first in vivo evidence of a pro-oncogenic role for SnoN in mammalian mammary tumorigenesis.
- SnoN acts as a cooperating oncogene in mammary cancer development and metastasis.
Related Concept Videos
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hedgehog Signaling Pathway
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

